Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 4
2010 2
2011 3
2012 5
2013 4
2014 4
2016 1
2017 1
2018 4
2019 1
2020 1
2021 10
2022 13
2023 10
2024 8
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper VE, Ombrello MJ, Tremoulet AH, Montero-Martin G, Prahalad S, Canna S, Shimizu C, Deutsch G, Tan SY, Remmers EF, Monos D, Hahn T, Phadke OK, Cassidy E, Ferguson I, Mallajosyula V, Xu J, Rosa Duque JS, Chua GT, Ghosh D, Szymanski AM, Rubin D, Burns JC, Tian L, Fernandez-Vina MA, Mellins ED, Hollenbach JA; Drug Hypersensitivity Consortium; INCHARGE Consortium. Saper VE, et al. Ann Rheum Dis. 2022 Mar;81(3):406-415. doi: 10.1136/annrheumdis-2021-220578. Epub 2021 Nov 17. Ann Rheum Dis. 2022. PMID: 34789453 Free PMC article.
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.
Saper VE, Tian L, Verstegen RHJ, Conrad CK, Cidon M, Hopper RK, Kuo CS, Osoegawa K, Baszis K, Bingham CA, Ferguson I, Hahn T, Horne A, Isupova EA, Jones JT, Kasapcopur Ö, Klein-Gitelman MS, Kostik MM, Ozen S, Phadke O, Prahalad S, Randell RL, Sener S, Stingl C, Abdul-Aziz R, Akoghlanian S, Al Julandani D, Alvarez MB, Bader-Meunier B, Balay-Dustrude EE, Balboni I, Baxter SK, Berard RA, Bhattad S, Bolaria R, Boneparth A, Cassidy EA, Co DO, Collins KP, Dancey P, Dickinson AM, Edelheit BS, Espada G, Flanagan ER, Imundo LF, Jindal AK, Kim HA, Klaus G, Lake C, Lapin WB, Lawson EF, Marmor I, Mombourquette J, Ogunjimi B, Olveda R, Ombrello MJ, Onel K, Poholek C, Ramanan AV, Ravelli A, Reinhardt A, Robinson AD, Rouster-Stevens K, Saad N, Schneider R, Selmanovic V, Sefic Pasic I, Shenoi S, Shilo NR, Soep JB, Sura A, Taber SF, Tesher M, Tibaldi J, Torok KS, Tsin CM, Vasquez-Canizares N, Villacis Nunez DS, Way EE, Whitehead B, Zemel LS, Sharma S, Fernández-Viña MA, Mellins ED; CARRA Registry Investigators. Saper VE, et al. Among authors: soep jb. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2996-3013.e7. doi: 10.1016/j.jaip.2024.07.002. Epub 2024 Aug 15. J Allergy Clin Immunol Pract. 2024. PMID: 39002722
EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).
Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, Aguiar CL, Akikusa JD, Akca UK, Almeida B, Appenzeller S, Balay-Dustrude E, Basaran O, Basiaga ML, Bilginer Y, Cabral DA, Capponi M, Donaldson N, Egeli BH, Fox EJ, Insalaco A, Iyer RS, Jansson AF, Kostik I, Kostik M, Kovalick LK, Kozu KT, Lapidus SK, Lee TC, Lenert A, Mahmood K, Marrani E, Mosad Mosa D, Muse I, Mushkin A, Nowicki KD, Nuruzzaman F, Onel K, Pardeo M, Pham TS, Potts L, Ramanan AV, Ravelli A, Rogers ND, Grim AW, Romano M, Rosenwasser N, Sato TS, Simonini G, Soep JB, Stern SM, Strauss T, Kohli AT, Theos AC, Tucker LB, Vogel LF, Yasin S, Wong SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. Zhao Y, et al. Among authors: soep jb. Ann Rheum Dis. 2025 Sep;84(9):1458-1468. doi: 10.1016/j.ard.2024.11.006. Epub 2025 Jan 30. Ann Rheum Dis. 2025. PMID: 39966038 Free article.
EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis.
Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, Aguiar CL, Akikusa JD, Akca UK, Almeida B, Appenzeller S, Balay-Dustrude E, Basaran O, Basiaga ML, Bilginer Y, Cabral DA, Capponi M, Donaldson N, Egeli BH, Fox EJ, Insalaco A, Iyer RS, Jansson AF, Kostik I, Kostik M, Kovalick LK, Kozu KT, Lapidus SK, Lee TC, Lenert A, Mahmood K, Marrani E, Mosa DM, Muse I, Mushkin A, Nowicki KD, Nuruzzaman F, Onel K, Pardeo M, Pham TS, Potts L, Ramanan AV, Ravelli A, Rogers ND, Grim AW, Romano M, Rosenwasser N, Sato TS, Simonini G, Soep JB, Stern SM, Strauss T, Kohli AT, Theos AC, Tucker LB, Vogel LF, Yasin S, Wong SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. Zhao Y, et al. Among authors: soep jb. Arthritis Rheumatol. 2025 May 8. doi: 10.1002/art.43137. Online ahead of print. Arthritis Rheumatol. 2025. PMID: 40342207
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.
Chang MH, Barbar-Smiley F, Akoghlanian S, Drew J, Angeles-Han ST, Quinlan-Waters M, Bohnsack JF, Cooper AM, Edelheit B, Twachtman-Bassett J, Lerman MA, Nanda K, Rabinovich CE, Lo MS; CARRA Uveitis Workgroup and the CARRA Registry Investigators. Chang MH, et al. Pediatr Rheumatol Online J. 2024 Oct 7;22(1):88. doi: 10.1186/s12969-024-01022-x. Pediatr Rheumatol Online J. 2024. PMID: 39375683 Free PMC article.
Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Mannion ML, Amin S, Balevic S, Chang ML, Correll CK, Kearsley-Fleet L, Hyrich KL, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators and the UK Juvenile Idiopathic Arthritis Biologics Register Investigators. Mannion ML, et al. Arthritis Care Res (Hoboken). 2024 Aug;76(8):1090-1098. doi: 10.1002/acr.25339. Epub 2024 May 7. Arthritis Care Res (Hoboken). 2024. PMID: 38556945 Free PMC article.
Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature.
Peng J, Dönnes P, Ardoin SP, Schanberg LE, Lewandowski L; APPLE trial investigators and Childhood Rheumatology Research Alliance (CARRA); Robinson G, Jury EC, Ciurtin C. Peng J, et al. Arthritis Rheumatol. 2024 Mar;76(3):455-468. doi: 10.1002/art.42722. Epub 2023 Dec 19. Arthritis Rheumatol. 2024. PMID: 37786302 Free PMC article. Clinical Trial.
68 results